Search for: "Astrazeneca"
Results 581 - 600
of 1,244
Sorted by Relevance
|
Sort by Date
11 Jul 2012, 5:00 am
AstraZeneca, L.P., Civ. [read post]
23 Nov 2020, 6:12 am
Another two-dose vaccine, that was 90% effective in the group that got a half-dose first, and then a full dose second (but less effective in the group that got a full dose each time). [read post]
8 Jan 2019, 4:09 am
Bart van WezenbeekFor establishing inventive step it is not necessary that the prior art contains a pointer for combination, only that in the relevant prior art an incentive was present to combine the prior art. [read post]
16 Aug 2017, 11:08 am
But the JPML was not convinced by their arguments, as seen from this excerpt from the Transfer Order: And, although it is true that AstraZeneca is sued in far more actions than Takeda, a significant number of actions are “mixed use” cases in which the plaintiffs allege use of more than one PPI, and sue Takeda and one or more other PPI manufacturers, including AstraZeneca. [read post]
14 Mar 2011, 9:50 am
Rank Patent Plaintiff Number of Cases Filed 1 Acacia 190 2 Laughlin Products 162 3 Pfizer 149 4 Monsanto Company 125 5 Ronald A Katz Technology Licensing 107 6 Patent Group (False Marking) 106 7 Novartis 104 8 Abbott Laboratories 103 9 Astrazeneca 80 10 Sanofi-Aventis 78 11 Oakley 77 12 Warner-Lambert Company 74 13 U.S. [read post]
1 Feb 2022, 9:01 am
Onglyza lawsuits claim that AstraZeneca ignored patient safety, launching the drug into the market before thoroughly studying the health risks on diabetes patients. [read post]
23 Oct 2008, 10:18 am
Make up your own mind about Lars Bildman, AstraZeneca's former CEO in the U.S. ...peterrost.blogspot.com/2007/05/former-us-astrazeneca-ceo-lars-bildman.html - 76k - Cached - Similar pages - Note thisAnd if you try to find big city lawyers, like Ronald Green, Epstein Becker & Green, ranked #7 you will find this:THE PETER ROST BLOG: Epstein Becker & Green settle Knicks ...Dec 11, 2007 ... [read post]
7 Jul 2010, 5:14 am
(Patent Docs) (Holman's Biotech IP Blog) US: AMP v USPTO after Bilski v Kappos (Patent Docs) US: NORD Chair/HP&M Director presents opening testimony at first ever FDA orphan drug hearing (FDA Law Blog) US: Celsis files patent infringement complaint against CellzDirect and Invitrogen over pooled multi-cryopreserved hepatocyte products (Patent Docs) Products Astelin (Azelastine) – US: Zydus admits infringing Meda’s Astelin patent, agrees not to market generic (Patent Docs)… [read post]
6 Jul 2010, 6:03 pm
(Patent Docs) (Holman’s Biotech IP Blog) US: AMP v USPTO after Bilski v Kappos (Patent Docs) US: NORD Chair/HP&M Director presents opening testimony at first ever FDA orphan drug hearing (FDA Law Blog) US: Celsis files patent infringement complaint against CellzDirect and Invitrogen over pooled multi-cryopreserved hepatocyte products (Patent Docs) Products Astelin (Azelastine) – US: Zydus admits infringing Meda’s Astelin patent, agrees not to market generic (Patent Docs)… [read post]
3 Nov 2010, 1:21 am
No – discussion of patent-eligibility standards for genes (Patent Baristas) US: Appellees file reply brief in Therasense v Becton Dickinson (Patent Docs) US: Another Capitol Hill missive objects to the inclusion of patent settlement provisions in FY 2011 Appropriations Bill (FDA Law Blog) US: REMS and 180-day exclusivity forfeiture – some interesting disclosures to the SEC (FDA Law Blog) Products Botox (Botulinum) – EU: General Court upholds opposition to BOTUMAX Community… [read post]
5 Feb 2013, 6:16 pm
RELATED READING: GSK Request for Advisory Opinion dated Jan. 10, 2005 AstraZeneca Request for Advisory Opinion dated Aug. 10, 2006 AstraZeneca Request for Advisory Opinion dated June 21, 2007 Forest Labs Request for Advisory Opinion dated May 12, 2011 [read post]
8 Mar 2012, 3:34 am
The federation, which goes by the acronym IFPMA, is led by David Brennan, an American who is also chief executive of AstraZeneca. [read post]
19 Feb 2020, 4:03 pm
Second, the consumer groups contend that AstraZeneca is a questionable buyer for brazikumab. [read post]
29 Aug 2016, 12:30 pm
For use as an example, here is the relevant part of an August 17, 2016 FDA Supplemental Approval letter to AstraZeneca Pharmaceuticals LP for Farxiga: Please refer to your supplemental New Drug Application (sNDA) dated and received July 28 2016, submitted under section 505(b) of the Federal Food, Drug, and Cosmetic Act (FDCA) for Farxiga (dapagliflozin) tablets. [read post]
17 May 2015, 6:28 am
3M, however, lives on in the continuing failure of all attempts at legislative correction to produce laws consistent with the approach taken in the rest of the developed world.In the latest chapter of this ongoing saga, on the 13th and 14th of May the Australian High Court heard oral arguments in the appeal by pharmaceutical company AstraZeneca AB against last year’s ruling of an expanded five-judge Full Bench of the Federal Court of Australia that its two patents relating to… [read post]
7 Jun 2021, 5:30 am
Here are our leading legal headlines for the week of June 7, 2021 from Wise Law on Twitter:Ontario backtracks, allows special fans for the Leafs game tonight Mixing vaccine brands is OK, Canada saysAmid calls for urgent action in response to deaths in residential schools, Ottawa says there’s no speedy solutionLawyer is fined after he flips the bird during Zoom oral argumentsThis New York firm is fighting mandatory COVID-19 vaccines with legal filings and warningsAs the Black Female… [read post]
6 Sep 2015, 12:30 am
Last week I predicted that the High Court would affirm the finding of five judges of the Federal Court of Australia that AstraZenenca’s patents covering low-dosage forms of the cholesterol-lowering drug marketed as CRESTOR (having the active ingredient rosuvastatin) are invalid on grounds of obviousness.In the much-anticipated decision in AstraZeneca AB v Apotex Pty Ltd (et al) [2015] HCA 30, five judges of the High Court, in four distinct concurring opinions, have unanimously… [read post]
21 Apr 2013, 1:42 am
In 1998 and 1999 he gave evidence on behalf of generic manufacturer Alphapharm Pty Ltd, in a dispute with originating pharmaceutical manufacturer Aktiebolaget Hässle (a member of the Astra group, now AstraZeneca) over a patent covering the compound omeprazole, better known as heartburn drug Prilosec (or, in some markets, Losec). [read post]
29 Jun 2018, 2:35 pm
ASTRAZENECA – SUPREME COURT Eelco Bergsma reports in the "EPLAW" Blog on this case which dealt with whether the description of the patent provided for a limiting definition of the claim.DesignsMoving on to some design news, the blog Marques reported that the Hague System expands to UK. [read post]
3 May 2021, 5:00 am
Here are our leading legal headlines for the week of May 3, 2021 from Wise Law on Twitter:EU suing AstraZeneca over delayed COVID-19 deliveriesToronto closes workplaces under emergency order to halt COVID-19 spreadToronto police attend over 200 gatherings, lay 160 charges for violations of Ontario’s stay-at-home order on the weekendGolf courses fighting for Ontario to reverse closure during pandemic stay-at-home orderB.C. judge orders second mother declared a third parent to… [read post]
